Page last updated: 2024-12-08

2-oxo-3-deoxygalactonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-dehydro-3-deoxy-D-galactonic acid : The 2-dehydro-3-deoxy derivative of D-galactonic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID194024
CHEBI ID17028
SCHEMBL ID6137475
MeSH IDM0063493

Synonyms (20)

Synonym
56742-44-0
CHEBI:17028
3-deoxy-d-threo-hex-2-ulosonic acid
2-dehydro-3-deoxy-d-galactonic acid
2-keto-3-deoxygluconate
C01216
2-keto-3-deoxy-d-gluconic acid
(4r,5r)-4,5,6-trihydroxy-2-oxohexanoic acid
2-oxo-3-deoxygalactonic acid
d-threo-2-hexulosonic acid, 3-deoxy-
3-deoxy-d-threo-hexulosonic acid
3-deoxy-d-threo hexulosonic acid
SCHEMBL6137475
LMFA01050486
3-deoxy-d-erythro-2-hexulosonate
2-keto-3-deoxy-d-galactonic acid lithium salt, analytical standard
Q27102178
(4r,5r)-4,5,6-tris(oxidanyl)-2-oxidanylidene-hexanoic acid
JBU ,
DTXSID201344318
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
ketoaldonic acidOxo carboxylic acids formally derived from aldonic acids by replacement of a secondary CHOH group by a carbonyl group.
hexonic acidAny aldonic acid formed by oxidising the aldehyde group of an aldohexose to a carboxylic acid group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Inner Membrane Transport7862
Hexuronide and Hexuronate Degradation1520

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (27.59)18.7374
1990's6 (20.69)18.2507
2000's5 (17.24)29.6817
2010's10 (34.48)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.13 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]